Xpert MTB/RIF Testing in a Low Tuberculosis Incidence, High-Resource Setting: Limitations in Accuracy and Clinical Impact
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in low-income countries. However, little information is available on its performance in low-incidence, high-resource countries. METHODS: We evaluated the accuracy of Xpert in a university hospital tuberculosis clinic in Montreal, Canada, for the detection of pulmonary tuberculosis on induced sputum samples, using mycobacterial cultures as the reference standard. We also assessed the potential reduction in time to diagnosis and treatment initiation. RESULTS: We enrolled 502 consecutive patients who presented for evaluation of possible active tuberculosis (most with abnormal chest radiographs, only 18% symptomatic). Twenty-five subjects were identified to have active tuberculosis by culture. Xpert had a sensitivity of 46% (95% confidence interval [CI], 26%-67%) and specificity of 100% (95% CI, 99%-100%) for detection of Mycobacterium tuberculosis. Sensitivity was 86% (95% CI, 42%-100%) in the 7 subjects with smear-positive results, and 28% (95% CI, 10%-56%) in the remaining subjects with smear-negative, culture-positive results; in this latter group, positive Xpert results were obtained a median 12 days before culture results. Subjects with positive cultures but negative Xpert results had minimal disease: 11 of 13 had no symptoms on presentation, and mean time to positive liquid culture results was 28 days (95% CI, 25-47 days) compared with 14 days (95% CI, 8-21 days) in Xpert/culture-positive cases. CONCLUSIONS: Our findings suggest limited potential impact of Xpert testing in high-resource, low-incidence ambulatory settings due to lower sensitivity in the context of less extensive disease, and limited potential to expedite diagnosis beyond what is achieved with the existing, well-performing diagnostic algorithm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is likely that patients in these settings present earlier with more paucibacillary disease, which might result in a decreased sensitivity of Xpert [45].”
From Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis (2014) · cites this paper as [45]
Citations
Cites
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124 · cited 2×
“We used Standards for the Reporting of Diagnostic Accuracy [18] [19] for reporting the study results.”
MethodXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Self-citationA systematic review of delay in the diagnosis and treatment of tuberculosis
Storla, D. G., Yimer, S., & Bjune, G. A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-15 · Cited by 1,018
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli
Behr, M., Warren, S., Salamon, H., Hopewell, P., de Leon, A. P., Daley, C., & Small, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03406-0 · Cited by 754
Self-citationTime delays in diagnosis of pulmonary tuberculosis: a systematic review of literature
Sreeramareddy, C. T., Panduru, K. V., Menten, J., & Van den Ende, J. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-91 · Cited by 455
Tostmann, A., Kik, S. V., Kalisvaart, N. A., Sebek, M. M., Verver, S., Boeree, M. J., & van Soolingen, D. (2008) · Clinical Infectious Diseases · doi:10.1086/591974 · Cited by 320
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253 · cited 2×
“The Xpert assay may enhance accurate and rapid detection, as it can detect up to 67% of smear-negative cases [1].”
BackgroundMethodSelf-citation
Research works printed but not linked: 4
- 2010, Public Health Agency of Canada. Tuberculosis in Canada 2010—pre-release
- Pai, 2013, Canadian Tuberculosis Standards, Canadian Resp J, 20, 16A
- Cepheid, 2013, Xpert MTB/RIF assay (package insert)
- Kent, 1985, Public health mycobacteriology—a guide for the level III laboratory
Cited by
Dorman, S. E., Schumacher, S. G., Alland, D., Nabeta, P., Armstrong, D. T., King, B., Hall, S. L., Chakravorty, S., Cirillo, D. M., Tukvadze, N., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30691-6 · Cited by 689
Self-citationChakravorty, S., Simmons, A. M., Rowneki, M., Parmar, H., Cao, Y., Ryan, J., Banada, P. P., Deshpande, S., Shenai, S., Gall, A., et al. (2017) · mBio · doi:10.1128/mbio.00812-17 · Cited by 668
Self-citationDrain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Self-citationAcharya, B., Acharya, A., Gautam, S., Ghimire, S. P., Mishra, G., Parajuli, N., & Sapkota, B. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05413-7 · Cited by 292
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
Horne, D. J., Kohli, M., Zifodya, J. S., Schiller, I., Dendukuri, N., Tollefson, D., Schumacher, S. G., Ochodo, E. A., Pai, M., & Steingart, K. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub4 · Cited by 267
Self-citationDefining the Needs for Next Generation Assays for Tuberculosis
Denkinger, C. M., Kik, S. V., Cirillo, D. M., Casenghi, M., Shinnick, T., Weyer, K., Gilpin, C., Boehme, C. C., Schito, M., Kimerling, M., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu821 · Cited by 167
Self-citationPET/CT imaging of Mycobacterium tuberculosis infection
Ankrah, A. O., van der Werf, T. S., de Vries, E. F. J., Dierckx, R., Sathekge, M. M., & Glaudemans, A. W. J. M. (2016) · Clinical and Translational Imaging · doi:10.1007/s40336-016-0164-0 · Cited by 134
Understanding the incremental value of novel diagnostic tests for tuberculosis
Arinaminpathy, N., & Dowdy, D. (2015) · Nature · doi:10.1038/nature16045 · Cited by 119
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF
Lombardi, G., Gregori, V. D., Girometti, N., Tadolini, M., Bisognin, F., & Monte, P. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176186 · Cited by 89
Whitworth, H. S., Badhan, A., Boakye, A., Takwoingi, Y., Rees-Roberts, M., Partlett, C., Lambie, H., Innes, J., Cooke, G., Lipman, M. C. I., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30613-3 · Cited by 84
Yan, L., Xiao, H., & Zhang, Q. (2016) · Tuberculosis · doi:10.1016/j.tube.2015.11.005 · Cited by 72
Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosis
Park, M., & Kon, O. M. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1810565 · Cited by 71
Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control
Stevens, W. S., Scott, L. E., Noble, L. D., Gous, N. M., & Dheda, K. U. J. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0040-2016 · Cited by 71
Lippincott, C. K., Miller, M. B., Popowitch, E. B., Hanrahan, C. F., & Rie, A. V. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu212 · Cited by 70
Luo, J., Zhang, M., Yan, B., Li, F., Guan, S., Chang, K., Jiang, W., Xu, H., Yuan, T., Chen, M., et al. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.10.017 · Cited by 66
Pu, X., Sheng, S., Fu, Y., Yang, Y., & Xu, G. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2416604 · Cited by 56
Schumacher, S. G., Sohn, H., Qin, Z. Z., Gore, G. C., Davis, J. L., Denkinger, C. M., & Pai, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151073 · Cited by 56
Self-citationPinyopornpanish, K., Chaiwarith, R., Pantip, C., Keawvichit, R., Wongworapat, K., Khamnoi, P., Supparatpinyo, K., & Sirisanthana, T. (2015) · Tuberculosis Research and Treatment · doi:10.1155/2015/571782 · Cited by 54
Cowan, J., Chandler, A. S., Kracen, E., Park, D. R., Wallis, C. K., Liu, E., Song, C., Persing, D. H., & Fang, F. C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw803 · Cited by 53
Rice, J. P., Seifert, M., Moser, K., & Rodwell, T. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186139 · Cited by 53
Davis, J. L., Kawamura, L. M., Chaisson, L. H., Grinsdale, J. A., Benhammou, J. N., Ho, C. S., Babst, A., Banouvong, H., Metcalfe, J. Z., Pandori, M., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-1974oc · Cited by 53
Lee, J. H., Garg, T., Lee, J., McGrath, S., Rosman, L. M., Schumacher, S. G., Benedetti, A., Qin, Z. Z., Gore, G. C., Pai, M., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07855-9 · Cited by 52
Self-citationPiersimoni, C., Gherardi, G., Gracciotti, N., & Pocognoli, A. (2019) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2019.100094 · Cited by 50
The implications of whole-genome sequencing in the control of tuberculosis
Lee, R. S., & Behr, M. A. (2015) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115624630 · Cited by 46
Self-citationTeste rápido molecular GeneXpert MTB/RIF para diagnóstico da tuberculose
Maschio-Lima, T., Belotti, N. C. U., Nardi, S. M. T., & Pedro, H. D. S. P. (2017) · Revista Pan-Amazônica de Saúde · doi:10.5123/s2176-62232017000200008 · Cited by 46
An update on multidrug-resistant tuberculosis
Park, M., Satta, G., & Kon, O. M. (2019) · Clinical Medicine · doi:10.7861/clinmedicine.19-2-135 · Cited by 43
Hu, X. L., Chen, H., Liao, S., Bai, H., Gupta, S., Zhou, J., Zhou, J., Jiao, L., Wu, L., Wang, M., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01973-19 · Cited by 41
Yi, X., Mao, Y. Q., Hua, X., Jiang, Y., Zou, Y., Wang, Z., Liu, Z., Zhang, H., Lu, L., & Yu, Y. (2025) · BMC Genomic Data · doi:10.1186/s12863-025-01338-x · Cited by 40
Lange, B., Khan, P. Y., Kalmambetova, G. I., Al‐Darraji, H. A. A., Alland, D., Antonenka, U., Brown, T., Balcells, M. E., Blakemore, R. L., Denkinger, C. M., et al. (2017) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.16.0702 · Cited by 39
Self-citationMetaferia, Y., Seid, A., Fenta, G. M., & Gebretsadik, D. (2018) · BioMed Research International · doi:10.1155/2018/8207098 · Cited by 38
Nuclear imaging: A powerful novel approach for tuberculosis
Johnson, D. H., Via, L. E., Kim, P. S., Laddy, D. J., Lau, C., Weinstein, E. A., & Jain, S. K. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.08.005 · Cited by 33
Performance evaluation of the Xpert MTB/RIF assay according to its clinical application
Huh, H. J., Jeong, B., Jeon, K., Koh, W., Ki, C., & Lee, N. Y. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0589-x · Cited by 28
Clinical implications of the global multidrug-resistant tuberculosis epidemic
Kumar, K., & Abubakar, I. I. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s37 · Cited by 27
Sander, M. S., Laah, S. N., Titahong, C. N., Lele, C., Kinge, T., de Jong, B. C., Abena, J.-L. F., Codlin, A. J., & Creswell, J. (2019) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2019.100095 · Cited by 22
Evaluation of the Cepheid Xpert MTB/RIF assay
Shinnick, T. M., Starks, A. M., Alexander, H. L., & Castro, K. G. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.976556 · Cited by 26
Jiang, J., Yang, J., Shi, Y., Jin, Y., Tang, S., Zhang, N., Lu, Y., & Sun, G. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2020.1788222 · Cited by 26
Keikha, M., & Karbalaei, M. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06708-1 · Cited by 23
Molecular diagnostics for tuberculosis
Noor, K., Shephard, L., & Bastian, I. (2015) · Pathology · doi:10.1097/pat.0000000000000232 · Cited by 23
Hodille, E., Maisson, A., Charlet, L., Bauduin, C., Genestet, C., Frédénucci, I., Rasigade, J., Lina, G., & Dumitrescu, O. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-03463-1 · Cited by 23
Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010–2013
Peralta, G., Barry, P. M., & Pascopella, L. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw230 · Cited by 21
Vinuesa, V., Borrás, R., Briones, M. L., Clari, M. Á., Cresencio, V., Giménez, E., Muñoz, C., Oltra, R., Servera, E., Carabelli, T. S., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00116-18 · Cited by 19
Molecular Diagnosis in Resource-Limited Settings
Rodrigues, C. S., Desai, N., & Fernandes, H. (2016) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2016.03.004 · Cited by 18
Issues Related to the Updated 2014 Korean Guidelines for Tuberculosis
Park, J. S. (2016) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2016.79.1.1 · Cited by 18
Bao, L., Li, T., Diao, N., Shen, Y., Shao, L., Zhang, Y., Lu, S., & Zhang, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0103763 · Cited by 17
Dharan, N. J., Blakemore, R., Sloutsky, A., Kaur, D., Alexander, R. C., Ghajar, M., Musser, K. A., Escuyer, V. E., Rowlinson, M., Crowe, S., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2039-4 · Cited by 17
Parcell, B. J., Jarchow-MacDonald, A., Seagar, A.-L., Laurenson, I. F., Prescott, G. J., & Lockhart, M. J. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.02.005 · Cited by 17
Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control
Stevens, W. S., Scott, L. E., Noble, L. D., Gous, N. M., & Dheda, K. U. J. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch18 · Cited by 16
Oxlade, O., Sugarman, J. A., Alvarez, G. G., Pai, M., & Schwartzman, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150119 · Cited by 15
Self-citationLópez-Roa, P., Martín-Higuera, M. C., Ruiz‐Serrano, M. J., Toro, C., Tato, M., Sacristán, M. S., Domingo, D., & Esteban, J. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115235 · Cited by 14
Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis
Lee, H. N., Kim, J. I., & Kim, Y. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250616 · Cited by 14
GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis
Cuong, N. K., Ngoc, N. B., Hoa, N. B., Dat, V. Q., & Nhung, N. V. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253961 · Cited by 14
Meier, N., Battegay, M., Ottenhoff, T. H. M., Furrer, H., Nemeth, J., & Ritz, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.620622 · Cited by 13
Alvarez, G. G., Dyk, D. D. V., Desjardlns, M., Yasseen, A. S., Aaron, S. D., Cameron, D. W., Obed, N., Baikie, M., Pakhale, S. S., Denklnger, C. M., et al. (2015) · CHEST Journal · doi:10.1378/chest.14-2948 · Cited by 13
Self-citationLyu, M., Zhou, J., Cheng, Y., Chong, W., Wu, K., Fang, T., Fu, T., & Ying, B. (2020) · Bioscience Reports · doi:10.1042/bsr20200308 · Cited by 11
Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis
Chen, G., Wang, H., & Wang, Y. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03768-9 · Cited by 11
Li, K., Hu, Q., Li, J., Liu, S., & He, Y. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08832-6 · Cited by 10
Das, S., Mangold, K. A., Shah, N. S., Peterson, L. R., Thomson, R. B., & Kaul, K. L. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa031 · Cited by 10
Mazzola, E., Monte, P. D., Piersimoni, C., Giudice, A. D., Camaggi, A., Pedrotti, C., Gurrieri, F., Russo, C., Farina, C., Lombardi, A. V., et al. (2021) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_200_20 · Cited by 10
Global trends of research on tuberculous pleurisy over the past 15 years: A bibliometric analysis
Bian, Y., Deng, M., Zhang, Q., & Hou, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.937811 · Cited by 9
Clinical implications of the global multidrug-resistant tuberculosis epidemic
Kumar, K., & Abubakar, I. I. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-6-565 · Cited by 9
Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting
Sulis, G., Agliati, A., Pinsi, G., Bozzola, G., Foccoli, P., Gulletta, M., Caligaris, S., Tomasoni, L. R., El‐Hamad, I., & Matteelli, A. (2018) · European Respiratory Journal · doi:10.1183/13993003.02345-2017 · Cited by 9
FujiLAM assays for tuberculosis detection in people with HIV: a systematic review and meta-analysis
Taye, B., Tesfaye, H., & Churiso, G. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12055-2 · Cited by 8
Kim, J. W., Patel, H., Halliwell, R., Free, R. C., Glimour-Caunt, A., Pareek, M., Woltmann, G., Verma, R., Perera, N., & Haldar, P. (2025) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2024-002624 · Cited by 8
Tuberculosis in Travelers and Immigrants
Narita, M., & Spitters, C. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37506-1.00025-8 · Cited by 8
Yang, Q., Zhang, C., Ruan, Q., Zhang, W., Zhang, H., Li, Y., Shao, L., & Zhang, W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.005 · Cited by 8
Sohn, H. (2016) · doi:10.82308/38621 · Cited by 8
Self-citationNotarte, K. I., Allen, K., Armstrong, D. T., & Parrish, N. M. (2026) · Journal of Clinical Microbiology · doi:10.1128/jcm.00082-26 · Cited by 7
Diagnosing pulmonary tuberculosis by pooling induced sputum
Chew, M. Y., Ng, J. S. K., & Lim, T. K. (2019) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2019.100100 · Cited by 7
Cheng, X., Chen, L., Wan, W., Peng, J., Wu, L., Xin, J., & Cai, J. (2024) · Medicine · doi:10.1097/md.0000000000037039 · Cited by 6
Saleeb, P. G., & Buchwald, U. K. (2014) · Pneumologie · doi:10.1055/s-0034-1377514 · Cited by 6
Hidden sources of bias in diagnostic studies: the example of visceral leishmaniasis in east Africa
van Griensven, J., Diro, E., & Yansouni, C. P. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00643-0 · Cited by 5
Tsuyuguchi, K., Nagai, H., Ogawa, K., Matsumoto, T., Morimoto, K., Takaki, A., & Mitarai, S. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.11.004 · Cited by 5
Advances in the Diagnosis of HIV-Associated Tuberculosis
Gupta‐Wright, A., & Lawn, S. D. (2015) · EMJ Respiratory · doi:10.33590/emjrespir/10313482 · Cited by 5
Baron, E. J., Tenover, F. C., & Gnanashanmugam, D. (2018) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2018.06.003 · Cited by 5
Quynh, T. T. N., Martinez, E. M., Menon, R., Anh, N. T. V., Hiển, N. T., Lân, N. H., Giang, D. C., Hằng, P. T., Thuong, P. H., Huan, H. V., et al. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.02.001 · Cited by 4
Performances and usefulness of Xpert MTB/RIF assay in low-incidence settings: not that bad?
Pham, T., Schrenzel, J., Janssens, J.-P., & Emonet, S. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03887-8 · Cited by 4
Salfinger, M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu024 · Cited by 4
Chida, N. M., & Shah, M. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw058 · Cited by 3
Shien, T. K., Jailaini, M. F. M., Azmel, A. A., Munusamy, V., Alaga, A., & Hamid, M. F. A. (2026) · Journal of Thoracic Disease · doi:10.21037/jtd-2026-1-0015 · Cited by 2
Madico, G. E., Vinhas, S. A., Orr, B. L., White, L. F., Gaeddert, M., Miller, N. S., Mpeirwe, M., Orikiriza, P., Mwanga‐Amumpaire, J., Boum, Y., et al. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.03.007 · Cited by 2
Leite, M. F., Carvalho, M. G. E. F. D., Ivazawa, M., Júnior, J. A. G. P., Rocha, T. K. D. A., Aureliano, F. S., & Gomes, V. T. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-237 · Cited by 2
Goyani, K. H., & Mukhopadhyaya, P. N. (2023) · Archives of Infectious Diseases & Therapy · doi:10.33140/aidt.07.03.01 · Cited by 2
Point-of-Care Technologies for the Diagnosis of Active Tuberculosis
(2016) · Molecular Microbiology · doi:10.1128/9781555819071.ch40 · Cited by 2
Prakash, K. A., Ramakrishnan, G. A., & Vasudevan, A. (2023) · Journal of Association of Pulmonologist of Tamil Nadu · doi:10.4103/japt.japt_39_23 · Cited by 2
Rapid detection of genetic mutations associated with drug-resistant mycobacterium tuberculosis
Seifert, M. (2015) · eScholarship (California Digital Library) · Cited by 1
Schumacher, S. (2016) · doi:10.82308/11450 · Cited by 1
Denkinger, C. M., & Pai, M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu376
Self-citationChaisson, L. H., & Davis, J. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ008
Performance of Xpert MTB/RIF in Induced Sputum Samples at Detecting Mycobacterium Tuberculosis
Sahly, H. M. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu375
Utilidad de las técnicas de amplificación genética en el diagnóstico de la tuberculosis
Sacristán, P. A. (2017) · UCrea (University of Cantabria)
Pleural procedures: training the trainee
Wu, Z., & Kadwani, O. (2019) · Clinical Medicine · doi:10.7861/clinmedicine.19-2-s135
Haraka, F. (2020) · edoc (University of Basel) · doi:10.5451/unibas-007229162
Needle in a haystack: Looking for tuberculosis in a low-incidence setting
Eckbo, E. J., Rodrigues, M., Hird, T. J., Ng, M., Lam, K., & Sekirov, I. (2021) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2020-0022
Weiler, T. (2011) · PubMed Central · doi:10.22028/d291-23315
Mitarai, S. (2022) · Respiratory disease series · doi:10.1007/978-981-19-3995-2_4
Lee, J. H., Garg, T., Lee, J., McGrath, S., Rosman, L., Schumacher, S. G., Benedetti, A., Qin, Z. Z., Gore, G., Pai, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26554436
Self-citationLi, K., Hu, Q., Liu, J., Liu, S., & He, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26645497
Metadata
- Authors
- Sohn, H., Aero, A. D., Menzies, D., Behr, M., Schwartzman, K., Alvarez, G. G., Dan, A., McIntosh, F., Pai, M., & Denkinger, C. M.
- Affiliations
- Montreal Chest Institute (CA)
- University of Ottawa (CA)
- McGill University (CA)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Sohn, Hojoon
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-14
- Volume
- 58
- Issue
- 7
- Pages
- 970-976
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2164800826
- Cited by
- 95
- References
- 24
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 9 · 2019: 11 · 2018: 6 · 2017: 8 · 2016: 13 · 2015: 13 · 2014: 10
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (MOP-89918)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Xpert MTB/RIF, tuberculosis diagnosis, Mycobacterium tuberculosis detection, diagnostic sensitivity, induced sputum, smear-negative tuberculosis, smear-positive tuberculosis, time to diagnosis, high-resource settings, low-incidence tuberculosis, automated molecular diagnostics, tuberculosis treatment initiation
- MeSH terms
- Adult, Canada, DNA, Bacterial, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Sensitivity and Specificity, Tuberculosis, Incidence, Developed Countries, Point-of-Care Systems, Nucleic Acid Amplification Techniques, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.